We are excited to share pre-clinical and some early clinical data for inobrodib which looks encouraging for patients with blood cancer https://t.co/oQTLhQYgHU
@TicketmasterUK a friend of mine has received the code to access the presale. But he got his ticket before. Could he try and buy the ticket for me? Does the owner of thevtickmaster account needs to be at the event? Or he can buy a ticket on my name?
@mikejonevans It depends on your job, if you can get one in London for 60k or more then London it is the right place. Especially if you want to focus on your career and get lots of money
@giorgionardini It really depends where you are based in london. LHR is west london, I would say STN is way more convenient for north Londoner or Luton even better
Two #postdoc and one predoc positions (wet or dry) are available in our Italian site in Milan to study #epigentics and #chromatin dysregulation in #cancer
CellCentric presenting at #ASH22. Exciting Phase I data treating RR multiple myeloma, and other haems. Inobrodib: small molecule p300/CBP inhibitor. https://t.co/pXZxA8BEqF